Psyence Biomedical Warrant
PBMWW
30 hedge funds and large institutions have $514K invested in Psyence Biomedical Warrant in 2024 Q1 according to their latest regulatory filings, with 30 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
EFI
EHP Funds Inc
Toronto,
Canada
|
+$76.8K |
| 2 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
+$45.7K |
| 3 |
MI
MMCAP International
Grand Cayman,
Cayman Islands
|
+$37.4K |
| 4 |
Calamos Advisors
Naperville,
Illinois
|
+$31.1K |
| 5 |
CF
Cantor Fitzgerald
New York
|
+$29.2K |
Top Sellers
PBMWW Hedge Fund Activity: Q1 2024 in Review
30 of the 6,958 institutional investors tracked by Wall St. Rank reported a position in Psyence Biomedical Warrant (PBMWW) for Q1 2024, worth a combined $514K.
Buyers outnumbered sellers: 30 funds opened new PBMWW positions and 0 closed out — a net gain of 30 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was EHP Funds Inc, opening a new position worth an estimated $76.8K.
- 30 institutional investors held Psyence Biomedical Warrant (PBMWW) as of Q1 2024, up from 0 in Q4 2023.
- Funds reported $514K of Psyence Biomedical Warrant stock for Q1 2024.
- 30 funds opened new Psyence Biomedical Warrant positions in Q1 2024 and 0 closed out, a net change of +30 holders.
- The largest Psyence Biomedical Warrant buyer in Q1 2024 was EHP Funds Inc, an estimated $76.8K added.
Based on aggregated 13F filings for Q1 2024.